Taste steering: a new way to help chemo patients enjoy their meals
NCT ID NCT07258563
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a home-based 'taste steering' program can improve food enjoyment for cancer patients undergoing chemotherapy. 201 adults with metastatic triple negative breast cancer, metastatic testicular cancer, or stage II-IV diffuse large B cell lymphoma will be randomly assigned to either the taste steering program or standard care. The program involves personalized guidance from a dietitian and at-home taste and smell exercises over 6 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
taste steering (behavioural intervention)
What this could lead to
If it works, this could give cancer patients a simple, at-home way to enjoy food more during chemotherapy, improving their quality of life.
What could go wrong
This is a relatively small, early-stage behavioural trial. The effect may be modest, and results might not apply to all cancer types or treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC TRIPLE NEGATIVE BREAST CANCER OR METASTATIC TESTICULAR CANCER, OR STAGE II-IV DIFFUSE LARGE B CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Amsterdam UMC
RECRUITINGAmsterdam, Netherlands
Contact
-
Ikazia Ziekenhuis
RECRUITINGRotterdam, Netherlands
Contact
-
Isala Klinieken
NOT_YET_RECRUITINGZwolle, Netherlands
Contact
-
Martini Ziekenhuis
RECRUITINGGroningen, Netherlands
Contact
-
Maxima Medisch Centrum
NOT_YET_RECRUITINGVeldhoven, Netherlands
Contact
-
Ommelander Ziekenhuis Groningen
RECRUITINGScheemda, Netherlands
Contact
-
Radboud University Medical Center
NOT_YET_RECRUITINGNijmegen, Netherlands
Contact
-
Rijnstate Ziekenhuis
NOT_YET_RECRUITINGArnhem, Netherlands
Contact
-
University Medical Center Groningen
RECRUITINGGroningen, 9713 GZ, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Van Weel-Bethesda Ziekenhuis
NOT_YET_RECRUITINGDirksland, Netherlands
Contact
-
Ziekenhuisvoorzieningen Gelderse Vallei
RECRUITINGEde, Netherlands
Contact